MARIA VIRGINIA DIAZ
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology HOUSTON, TX NPI 1356791693
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology TX Genentech USA, Inc. All categories
General Payments — all program years on this page
$433.73
- Category: General Payments
- Program years: PY2021–2024
- Record count: 12
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $204.25 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $204.25 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Genentech USA, Inc. | $137.63 | 5 |
| Alexion Pharmaceuticals, Inc. | $25.98 | 1 |
| Vanda Pharmaceuticals Inc. | $20.88 | 1 |
| Neurelis, Inc. | $19.76 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1093914038 | Alexion Pharmaceuticals, Inc. | $25.98 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133060558 | Genentech USA, Inc. | $28.79 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133060562 | Genentech USA, Inc. | $30.31 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133060566 | Genentech USA, Inc. | $26.91 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133060570 | Genentech USA, Inc. | $27.62 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133060574 | Genentech USA, Inc. | $24.00 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133901241 | Vanda Pharmaceuticals Inc. | $20.88 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145640184 | Neurelis, Inc. | $19.76 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.